Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients
作者： Liyan Miao , Jian Yang , Chenrong Huang , Zhenya Shen
DOI: 10.1007/S00228-007-0381-6
关键词: Surgery 、 Anticoagulant 、 Vitamin K epoxide reductase 、 Pharmacogenetics 、 CYP2C9 、 Vitamin-K-epoxide reductase (warfarin-sensitive) 、 VKORC1 、 Internal medicine 、 Biology 、 Anthropometry 、 Warfarin 、 Pharmacology (medical) 、 Pharmacology 、 General Medicine
摘要: Objective The objective of this study was to assess the contribution VKORC1 and CYP2C9 genotypes age, body size, weight patients warfarin dose requirement in a Chinese population.
springer.com
sci-hub.se 参考文章(28)
Farhad Kamali, Tayyaba Irfan Khan, Barry P King, Richard Frearson, Patrick Kesteven, Peter Wood, Ann K Daly, Hilary Wynne, Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin. Clinical Pharmacology & Therapeutics. ,vol. 75, pp. 204- 212 ,(2004) , 10.1016/J.CLPT.2003.10.001
Hugo Kohnke, Kristina Sörlin, Göran Granath, Mia Wadelius, Warfarin dose related to apolipoprotein E ( APOE ) genotype European Journal of Clinical Pharmacology. ,vol. 61, pp. 381- 388 ,(2005) , 10.1007/S00228-005-0936-3
Leslie Y. Chen, Niclas Eriksson, Rhian Gwilliam, David Bentley, Panos Deloukas, Mia Wadelius, Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing. Blood. ,vol. 106, pp. 3673- 3674 ,(2005) , 10.1182/BLOOD-2005-04-1711
M Wadelius, K Sörlin, O Wallerman, J Karlsson, Q-Y Yue, P K E Magnusson, C Wadelius, H Melhus, Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors Pharmacogenomics Journal. ,vol. 4, pp. 40- 48 ,(2004) , 10.1038/SJ.TPJ.6500220
Michael A Hillman, Russell A Wilke, Michael D Caldwell, Richard L Berg, Ingrid Glurich, James K Burmester, Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype. Pharmacogenetics. ,vol. 14, pp. 539- 547 ,(2004) , 10.1097/01.FPC.0000114760.08559.DC
Simone Rost, Andreas Fregin, Vytautas Ivaskevicius, Ernst Conzelmann, Konstanze Hörtnagel, Hans-Joachim Pelz, Knut Lappegard, Erhard Seifried, Inge Scharrer, Edward G. D. Tuddenham, Clemens R. Müller, Tim M. Strom, Johannes Oldenburg, Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 Nature. ,vol. 427, pp. 537- 541 ,(2004) , 10.1038/NATURE02214
T. J. Wilkinson, R. Sainsbury, Evaluation of a warfarin initiation protocol for older people. Internal Medicine Journal. ,vol. 33, pp. 465- 467 ,(2003) , 10.1046/J.1445-5994.2003.00452.X
Manuela Vecsler, Ronen Loebstein, Shlomo Almog, Daniel Kurnik, Boleslav Goldman, Hillel Halkin, Eva Gak, Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin Thrombosis and Haemostasis. ,vol. 95, pp. 205- 211 ,(2006) , 10.1160/TH05-06-0446
A Fennerty, J Dolben, P Thomas, G Backhouse, D P Bentley, I A Campbell, P A Routledge, Flexible induction dose regimen for warfarin and prediction of maintenance dose. BMJ. ,vol. 288, pp. 1268- 1270 ,(1984) , 10.1136/BMJ.288.6426.1268
M Wadelius, L Y Chen, K Downes, J Ghori, S Hunt, N Eriksson, O Wallerman, H Melhus, C Wadelius, D Bentley, P Deloukas, Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics Journal. ,vol. 5, pp. 262- 270 ,(2005) , 10.1038/SJ.TPJ.6500313